Basics Aytu BioScience, Inc. Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. IPO Date: May 23, 2017 Sector: Healthcare Industry: Pharma Market Cap: $23.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.88% Avg Daily Range (30 D): $0.08 | 3.58% Avg Daily Range (90 D): $0.06 | 2.57% Institutional Daily Volume Avg Daily Volume: 1.52M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 440 Avg Trade Size (Sh.) (30 D): 228 Avg Trade Size (Sh.) (90 D): 233 Institutional Trades Total Inst.Trades: 60 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.76M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.59M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 20.99K     News Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A Nov 15, 2023 @ 7:04 PM Why Shapeways Holdings Shares Are Trading Lower By... Source: Lisa Levin Sep 28, 2023 @ 5:04 PM Why CarMax Shares Are Trading Lower By Around 10%?... Source: Lisa Levin Sep 28, 2023 @ 3:55 PM Best Penny Stocks? 4 Hot Stocks With News This Wee... Source: J. Samuel Aug 9, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Au... Source: Benzinga Insights Financials   TTM Q4 2025 FY 2025 Basic EPS $-2.16 $-3.18 $-2.16 Diluted EPS Revenue $ 66.38M $ 15.14M $ 66.38M Gross Profit $ 45.83M $ 10.25M $ 45.83M Net Income / Loss $ -13.56M $ -19.82M $ -13.56M Operating Income / Loss $ -7.83M $ -7.62M $ -7.83M Cost of Revenue $ 20.55M $ 4.88M $ 20.55M Net Cash Flow $ 10.95M $ 12.78M $ 10.95M PE Ratio     Splits Jan 06, 2023:   1:20 Dec 09, 2020:   1:10 Aug 13, 2018:   1:20 Aug 29, 2017:   1:20 Jul 01, 2016:   1:12 Jun 10, 2015:   11:134